Do OA - Search Results

1

Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.

Wong RL, Ferris LA, Do OA, Holt SK, Ramos JD, Crabb SJ, Sternberg CN, Bellmunt J, Ladoire S, De Giorgi U, Harshman LC, Vaishampayan UN, Necchi A, Srinivas S, Pal SK, Niegisch G, Dorff TB, Galsky MD, Yu EY. Wong RL, et al. Among authors: do oa. Oncologist. 2021 Dec;26(12):1026-1034. doi: 10.1002/onco.13925. Epub 2021 Aug 17. Oncologist. 2021. PMID: 34355457 Free PMC article.

2

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.

Do OA, Ferris LA, Holt SK, Ramos JD, Harshman LC, Plimack ER, Crabb SJ, Pal SK, De Giorgi U, Ladoire S, Baniel J, Necchi A, Vaishampayan UN, Bamias A, Bellmunt J, Srinivas S, Dorff TB, Galsky MD, Yu EY. Do OA, et al. Clin Genitourin Cancer. 2021 Apr;19(2):125-134. doi: 10.1016/j.clgc.2020.10.006. Epub 2020 Nov 12. Clin Genitourin Cancer. 2021. PMID: 33309564

3

Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.

Konuthula N, Do OA, Gobillot T, Rodriguez CP, Futran ND, Houlton J, Barber BR. Konuthula N, et al. Among authors: do oa. Head Neck. 2022 Nov;44(11):2465-2472. doi: 10.1002/hed.27162. Epub 2022 Aug 5. Head Neck. 2022. PMID: 35930296

4

Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.

Francis SR, Ager BJ, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK. Francis SR, et al. Among authors: do oa. Gynecol Oncol. 2019 Jul;154(1):38-44. doi: 10.1016/j.ygyno.2019.04.676. Epub 2019 Apr 24. Gynecol Oncol. 2019. PMID: 31029507

5

Trust in physicians among patients with head and neck cancer before and after treatment.

Highland J, Aylward A, Do O, Monroe M, Buchmann L. Highland J, et al. Head Neck. 2021 Sep;43(9):2580-2588. doi: 10.1002/hed.26721. Epub 2021 Apr 26. Head Neck. 2021. PMID: 33899296

6

Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?

Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK. Ager BJ, et al. Among authors: do oa. Brachytherapy. 2019 Jul-Aug;18(4):453-461. doi: 10.1016/j.brachy.2019.03.001. Epub 2019 Apr 17. Brachytherapy. 2019. PMID: 31005603

7

Return-to-School Experiences of Adolescents After Allogeneic Hematopoietic Cell Transplant: A Qualitative Interview Study of Transplant Recipients.

Do OA, Ohlsen TJD, Shipman KJ, Ballard SA, Jenssen KM, Baker KS, Rosenberg AR, Barton KS, Bhatt NS. Do OA, et al. Pediatr Blood Cancer. 2024 Dec 17:e31481. doi: 10.1002/pbc.31481. Online ahead of print. Pediatr Blood Cancer. 2024. PMID: 39690453

8

3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.

Nakamura S, Kenjo H, Nishio T, Kazama T, Do O, Suzuki K. Nakamura S, et al. Breast Cancer. 2001;8(4):351-4. doi: 10.1007/BF02967536. Breast Cancer. 2001. PMID: 11791129 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters